Luke Düster
Direttore/Membro del Consiglio presso VALERITAS INC
Profilo
Luke Düster is a member of CRG’s Founders Group, serves as Chief Investment Officer, ESG Champion and a Member of CRG’s Investment Committee and ESG Committee.
He is also responsible for portfolio management and portfolio company exits.
Mr. Düster also serves on the board of directors of several CRG portfolio companies, both as a director and as an observer, and serves portfolio company senior management teams as an advisor on financial, strategic and operational initiatives.
He has led investments in companies such as Neotract, Nevro, Omeros, BioDelivery Sciences, Strongbridge Biopharma, Silk Road Medical, NanoString Technologies and many others.
Prior to CRG, Mr. Düster was an investment banker at Harris Williams & Co., where he advised private equity and corporate clients across a broad range of M&A assignments.
Mr. Düster also held investment banking roles at the Wallach Company, a regional investment banking boutique, and at the Nord Companies, a healthcare advisory firm.
Mr. Düster received a bachelor’s degree from the University of Colorado at Boulder in 1997, where he graduated summa cum laude.
He received an M.B.A with honors from the Wharton School at the University of Pennsylvania in 2004.
Posizioni attive di Luke Düster
| Società | Posizione | Inizio |
|---|---|---|
| VALERITAS INC | Direttore/Membro del Consiglio | 01/01/2016 |
CR Group LP
 CR Group LP Investment ManagersFinance CR Group LP (CRG) is a venture capital firm founded in 2003 by Charles Tate. The firm is headquartered in Houston, Texas. | Direttore degli Investimenti | - |
Precedenti posizioni note di Luke Düster
| Società | Posizione | Fine |
|---|---|---|
| VALERITAS HOLDINGS, INC. | Direttore/Membro del Consiglio | 21/12/2019 |
| ZYLA LIFE SCIENCES | Direttore/Membro del Consiglio | 18/06/2019 |
Harris Williams & Co.
 Harris Williams & Co. Investment Banks/BrokersFinance Harris Williams & Co. provides investment advisory services. It offers investment banking, sell-side mergers and acquisitions, capital raising, fairness opinion, and restructuring advisory services. The company was founded by H. Hiter Harris III and Christopher H. Williams in 1991 and is headquartered in Richmond, VA. | Corporate Officer/Principal | 01/01/2009 |
| Wallach Co. | Corporate Officer/Principal | 01/01/2002 |
Formazione di Luke Düster
| University of Colorado Boulder | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
CR Group LP
CR Group LP Investment ManagersFinance CR Group LP (CRG) is a venture capital firm founded in 2003 by Charles Tate. The firm is headquartered in Houston, Texas. | Finance |
Harris Williams & Co.
Harris Williams & Co. Investment Banks/BrokersFinance Harris Williams & Co. provides investment advisory services. It offers investment banking, sell-side mergers and acquisitions, capital raising, fairness opinion, and restructuring advisory services. The company was founded by H. Hiter Harris III and Christopher H. Williams in 1991 and is headquartered in Richmond, VA. | Finance |
| Wallach Co. | Finance |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Valeritas, Inc. engages in the development and commercialization of drug delivery solutions for the treatment of diabetes. Its product, V-Go wearable insulin delivery device, which enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin at a continuous preset basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. The company was founded on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
Valeritas Holdings, Inc.
 Valeritas Holdings, Inc. Medical SpecialtiesHealth Technology Valeritas Holdings, Inc. develops and commercializes insulin delivery devices. The company was founded by Leisa Swanson and Robert R. Gonnelli on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
- Borsa valori
- Insiders
- Luke Düster
